Editing Johnson & Johnson (section)

=== Patent-infringement case against Abbott ===
In 2007, Johnson & Johnson sued [[Abbott Laboratories]] over the development and sale of the arthritis drug [[Humira]], claiming Abbott used technology licensed exclusively to Johnson & Johnson's [[Centocor]] division. Johnson & Johnson won the court case, and in 2009 Abbott was ordered to pay Johnson & Johnson $1.17{{nbs}}billion in lost revenues and $504{{nbs}}million in royalties.<ref name=Bloomberg2009>[https://www.bloomberg.com/apps/news?pid=newsarchive&sid=aF0Qoxe0JCiw Abbott Told to Pay Record $1.67{{nbs}}billion Award to J&J], ''Bloomberg News'', June 29, 2009</ref> The judge also added $175.6{{nbs}}million in interest to bring the total to $1.84{{nbs}}billion.<ref name= bloomberg2010>[https://www.bloomberg.com/news/2010-11-02/abbott-challenges-1-67-billion-patent-loss-to-j-j-over-arthritis-therapy.html Abbott Challenges $1.67{{nbs}}billion Patent Loss to J&J Over Humira], ''Bloomberg News'', November 2, 2010</ref> This was the largest patent-infringement award in U.S. history<ref name=Bloomberg2009/> until the 2013 decision against Teva in favor of [[Takeda Pharmaceutical Company|Takeda]] and [[Pfizer]] for over $2.1{{nbs}}billion.<ref name= WSJ2013>[https://online.wsj.com/news/articles/SB10001424127887324188604578541080995659790 Pfizer, Takeda to Get $2.15{{nbs}}Billion Settlement], ''WSJ'', December 6, 2013</ref> In 2010 Abbott appealed the verdict<ref name= bloomberg2010/> and in 2011 won the appeal.<ref name="BusinessWeek2011">{{Cite web|url=http://www.businessweek.com/news/2011-02-23/abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory.html|title=abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory|work=[[Bloomberg News|Bloomberg]]|url-status=dead|archive-url=https://web.archive.org/web/20110506001424/http://www.businessweek.com/news/2011-02-23/abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory.html|archive-date=May 6, 2011}}</ref>